Choline acetyltransferase–expressing T cells are required to control chronic viral infection
Maureen A. Cox(University Health Network), Tak W. Mak(University Health Network), Benjamin E. Steinberg(Hospital for Sick Children), Luke N. Buckler(University Health Network), Jillian Haight(University Health Network), Andrew Wakeham(Ontario Institute for Cancer Research), Kevin J. Tracey(Northwell Health), Kyle T. Gill(University Health Network), Brian J. Nieman(Ontario Institute for Cancer Research), Shawn P. Kubli(University of Toronto), Pamela S. Ohashi(University Health Network), Peder S. Olofsson(Feinstein Institute for Medical Research), Carmen Dominguez‐Brauer(University Health Network), Andrew Elia(Ontario Institute for Cancer Research), Dirk Brenner(University of Luxembourg), Lisa Yu(Columbia University Irving Medical Center), Gloria Lin(Pfizer (Canada)), Alisha R. Elford(Ontario Institute for Cancer Research), Gordon S. Duncan(Ontario Institute for Cancer Research), Thorsten Berger(University Health Network)
Cited by 158
Related Papers
Sepsis: a roadmap for future research
|The Lancet Infectious Diseases|2015|1k
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
|European Journal of Immunology|2019|1k
Regulation of tumour necrosis factor signalling: live or let die
|Nature reviews. Immunology|2015|994
TNF and ROS Crosstalk in Inflammation
|Trends in Cell Biology|2016|986
Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes
|Genes & Development|1998|841